27.12.1939
6593932
oleg.kurtenkov@tai.ee

Career

Institutions and positions
01.01.2015–...   
National Institute for Health Development, head, department of oncology and immunology (0,50)
2003–31.12.2014   
National Institute for Health Development, head, department of oncology and immunology (1,00)
01.01.1991–31.12.2003   
IECM, head of the Department of Experimental Oncology.
01.01.1974–31.12.1991   
­IECM, senior researcher
01.01.1970–31.12.1974   
­IECM, researcher
01.01.1967–31.12.1969   
postgraduate student. Department of Oncology, Institute of Experimental and Clinical Medicine (IECM), Tallinn
01.01.1965–31.12.1967   
intern in surgery at Central Hospital, Tallinn
01.01.1962–31.12.1965   
surgeon, Tula district, Russia
 
 
Education
1990–...   
Advanced course at Roswell Park Cancer Institute, Buffalo, New York, USA
1956–1962   
Leningrad Ist Medical Institute, physician
 
 
R&D related managerial and administrative work
1995−...   
New York Academy of Sciences, member
1995−...   
Baltic Immunological Society, member
1992−...   
Estonian Immunological Society, member
 
 
Creative work
Patent
Kurtenkov Oleg and Smorodin Jevgeni. "Gastric cancer diagnostic method" SU 1300678 A1, 1.12.1986.

Publications

Category
Year
Publication
 
1.1.
2018
1.1.
2015
1.1.
2014
1.1.
2014
3.1.
2014
1.1.
2013
1.1.
2013
1.1.
2012
1.1.
2011
1.2.
2011
1.1.
2010
5.2.
2010
5.2.
2010
5.2.
2010
1.1.
2009
1.1.
2009
31.05.2019
27.12.1939
6593932
oleg.kurtenkov@tai.ee

Teenistuskäik

Töökohad ja ametid
01.01.2015–...   
Tervise Arengu Instituut, onkoloogia ja immunoloogia osakonna juhataja (0,50)
2003–31.12.2014   
Tervise Arengu Instituut, onkoloogia ja immunoloogia osakonna juhataja (1,00)
01.01.1991–31.12.2003   
Eksperimentaalse ja Kliinilise Meditsiini Instituut (EKMI), eksperimentaalse onkoloogia osakonna juhataja
01.01.1974–31.12.1991   
EKMI, vanemteadur
01.01.1970–31.12.1974   
EKMI, teadur
01.01.1967–31.12.1969   
EKMI, aspirantuur onkoloogia alal
01.01.1965–31.12.1967   
Tallinna Keskhaigla, internatuur kirurgia alal
01.01.1962–31.12.1965   
Tuula oblast, Venemaa, kirurg
 
 
Haridustee
1990–...   
Täiendõpe USA Roswell Park Cancer Institute, Buffalo, New York (aprill-mai 1990)
1956–1962   
Leningradi I Meditsiini Instituut, arstiteaduskond, ravi eriala, arsti kvalifikatsioon
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
1995−...   
New York´i Teaduste Akadeemia liige
1995−...   
Eesti Immunoloogide Seltsi liige
1992−...   
Balti Immunoloogide Seltsi liige
 
 
Loometöö
Ühe leiutise autor:
Kurtenkov Oleg ja Smorodin Jevgeni. " Mao vähi ja healoomuliste haiguste diferentsiaaldiagnostika meetod" Eksperimentaalse ja Kliinilise Meditsiini Instituut. Autoritunnistus nr SU1300678 A1. NSV Liidu Leiutiste ja Avastuste Komitee. 1.12.1986..

Lõppenud projektid

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2018
1.1.
2015
1.1.
2014
1.1.
2014
3.1.
2014
1.1.
2013
1.1.
2013
1.1.
2012
1.1.
2011
1.2.
2011
1.1.
2010
5.2.
2010
5.2.
2010
5.2.
2010
1.1.
2009
1.1.
2009
31.05.2019
  • Found 6 results
ProgramTypeNumberNameProject startProject endPrincipal investigatorInstitutionFinancing
ETFETF8399Autoantibodies to tumor-associated Thomsen-Friedenreich (TF) disaccharide: antibody subpopulations, TF glycotope natural carriers, and relation to cancer progression01.01.201031.12.2013Oleg KurtenkovNational Institute for Health Development64 069,95 EUR
SFSF0192109s02Helicobacter pylori infection and gastroduodenal pathology: host-dependent and microbial factors in clinical outcome of the infection (chronic gastritis, peptic ulcer, gastric cancer.01.01.200231.12.2006Oleg KurtenkovNational Institute for Health Development277 057,00 EUR
ETFETF6726Immune response to synthetic and natural tumor-associated carbohydrate antigens in patients with cancer: the specificity of IgG antibodies and their clinical significance01.01.200631.12.2009Oleg KurtenkovNational Institute for Health Development49 344,92 EUR
ETFETF7317The glycosylation of autoantibodies to tumor-associated antigens in cancer and premalignant conditions01.01.200831.12.2011Kersti KlaamasNational Institute for Health Development66 953,95 EUR
PUT; PUT_OPPUT371Aberrant glycosylation of autoantibodies to tumor–associated glycans in cancer diagnostics and prognostics. 01.01.201431.12.2017Kersti KlaamasNational Institute for Health Development163 200,00 EUR
SFSF0140145Bs08Immunology of tumor progression: profiling of the immune response to tumor-associated antigens in the diagnosis, monitoring and prognosis of cancer01.01.200831.12.2013Oleg KurtenkovNational Institute for Health Development598 694,01 EUR